deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiation.
Mainardi
S
S
Pelosi
A
A
Palescandolo
E
E
Riccioni
R
R
Fontemaggi
G
G
Diverio
D
D
Testa
U
U
Sacchi
A
A
Grignani
F
F
Lo-Coco
F
F
Levrero
M
M
Blandino
G
G
Rizzo
M G
MG
D001483:Base Sequence; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000235:genetics*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008969:Molecular Sequence Data; D038042:Myelopoiesis / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D011401:Promoter Regions, Genetic; D014158:Transcription, Genetic; D014212:Tretinoin / Q000494:pharmacology; D025521:Tumor Suppressor Proteins / Q000235:genetics*
D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion; D025521:Tumor Suppressor Proteins; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014212:Tretinoin